2022 Scientific Sessions

Thyroid Monitoring Following Administration of Iodine-Containing Contrast: What the New FDA Recommendations Mean for Congenital Cardiac Catheterization

The Science Behind Hypothyroidism and Iodinated Contrast
Shyam K. Sathanandam, M.D., FSCAI, Le Bonheur Children's Hospital, Memphis, TN
View Recording Download Slides
Background and Review of the Literature Behind the FDA Recommendations
Arash Salavitabar, M.D., FSCAI, Nationwide Children's Hospital, Columbus, OH
View Recording Download Slides
FDA Recommendations and Intent
Vasum Peiris, MD, Office of Strategic Partnerships and Technology Innovation; U.S. Food and Drug Administration, Washington, DC
View Recording
Response to and Implementation of the FDA Recommendations
Audrey C. Marshall, MD, FSCAI, The Hospital for Sick Children, Toronto, ON, CANADA
View Recording Download Slides
See more of: Congenital Heart Disease
<< Previous Session | Next Session >>